Cited by 380Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

Open access

BOTTO, GIOVANNI L., PADELETTI, LUIGI, SANTINI, MASSIMO, CAPUCCI, ALESSANDRO, GULIZIA, MICHELE, ZOLEZZI, FRANCESCO, FAVALE, STEFANO, MOLON, GIULIO, RICCI, RENATO, BIFFI, MAURO, RUSSO, GIOVANNI, VIMERCATI, MARCO, CORBUCCI, GIORGIO, BORIANI, GIUSEPPE·2009·Journal of Cardiovascular Electrophysiology

DOI 10.1111/j.1540-8167.2008.01320.x

Open this paper in CoChat — free account

Abstract

INTRODUCTION: Asymptomatic atrial fibrillation (AF) can expose patients to the risk of stroke. The primary objective of this study was to assess the incidence of thromboembolic events in relationship with CHADS(2) (congestive heart failure, hypertension, age >or=75 years, diabetes mellitus, and prior stroke, or transient ischemic attack) score and AF presence/duration. The secondary objective was to compare intermittent versus continuous monitoring strategies. METHODS AND RESULTS: Data from patients with an implanted pacemaker and a history of AF were analyzed. Thromboembolic risk was quantified through CHADS(2) score. Three AF groups were considered: patients with <5-minutes AF on 1 day (AF-free); patients with >5-minutes AF on 1 day but <24 hours (AF-5 minutes); patients with AF episodes >24 hours (AF-24 hours). Monitoring strategies involving 24-hour Holter, 1-week Holter, and 30-day Holter were simulated. Data from 568 patients continuously monitored for 1 year were analyzed: 171 (30%) had CHADS(2) score = 0; 269 (47%) had CHADS(2) score = 1; 111 (20%) had CHADS(2) score = 2; and 17 (3%) had CHADS(2) score >or= 3. During follow-up, 14 patients (2.5%) had an ischemic thromboembolic event. AF-24 hours patients numbered 223 (39.2%); AF-5 minutes, 179 (31.5%); and AF-free, 29.2%. By combining AF presence/duration with CHADS(2) score, two subpopulations with markedly different risks of events (0.8% vs 5%, P = 0.035) were identified, the former corresponding to AF-free with CHADS(2) 5 minutes was 44.4%, 50.4%, and 65.1% for 24-hour Holter, 1-week Holter, and 1-month Holter monitoring, respectively. CONCLUSION: In patients with recurrent AF episodes, risk stratification for thromboembolic events can be improved by combining CHADS(2) score with AF presence/duration.

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2008.01320.x

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
Petersen, P., GODTFREDSEN, J., Boysen, G., Andersen, E. D., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,814
Stroke Prevention in Atrial Fibrillation Study. Final results.
Prevention, S., & Atrial Fibrillation Investigators (1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators* (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,525
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,273
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H. J., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,204
Canadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. D. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,109

Flagged first, then by citations

Show all 40 references

Research works printed but not linked: 5

10.1046/j.1540-8167.2001.01121.x · DOI
10.1161/01.CIR.101.8.878 · DOI
10.1111/j.1540-8167.2006.00609.x · DOI
10.1136/hrt.2006.099911 · DOI
10.1111/j.1540-8167.2008.01194.x · DOI

Sorted by citations

Items 201–300 of 378

Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial Fibrillation
Elkind, M. S. V., Wachter, R., Verma, A., Kowey, P. R., Halperin, J. L., Gersh, B. J., Ziegler, P., Pouliot, E., Franco, N. C., & Reiffel, J. A. (2021) · Cardiology · doi:10.1159/000517827 · Cited by 10
Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis
Negreva, M. N., Georgiev, S., & Vitlianova, K. (2016) · Medicine · doi:10.1097/md.0000000000005184 · Cited by 10
Monitoring for AF: Identifying the Burden of Atrial Fibrillation and Assessing Post-Ablation
PASSMAN, R. S. (2017) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2017.080104 · Cited by 10
Prediction of Stroke Risk in Atrial Fibrillation, Prevention of Stroke in Atrial Fibrillation, and the Impact of Long-Term Monitoring for Detecting Atrial Fibrillation
Thomas, G., & Lerman, B. B. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0188-x · Cited by 10
Atrial Fibrillation Therapies: Lest We Forget Surgery
Toeg, H. D., Al‐Atassi, T., & Lam, B.-K. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.02.001 · Cited by 10
Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices
Miyazawa, K., Kondo, Y., Nakano, M., Esteve‐Pastor, M. A., Rivera‐Caravaca, J. M., Senoo, K., Kobayashi, Y., & Lip, G. Y. H. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.019 · Cited by 10
Cost‐effectiveness of insertable cardiac monitors for diagnosis of atrial fibrillation in cryptogenic stroke in Australia
Thijs, V., Witte, K. K., Guarnieri, C., Makino, K., Tilden, D., Gillespie, J., & Huynh, M. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12586 · Cited by 9
Atrial myopathy
Gondal, M. U. R., Mehmood, R. S., Khan, R. P., & Malik, J. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102381 · Cited by 9
Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System
Perlini, S., Belluzzi, F., Salinaro, F., & Musc, F. (2013) · InTech eBooks · doi:10.5772/53917 · Cited by 9
How to use implantable loop recorders in clinical trials and hybrid therapy
Jung, W., Zvereva, V., Rillig, A., Roggenbuck, B., Sadeghzadeh, G., & Kohler, J. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-011-9611-z · Cited by 9
Electrocardiographic Monitoring for Prevention of Atrial Fibrillation–Associated Cardioembolic Stroke
Goldberger, J. J., & Mitrani, R. D. (2018) · JAMA · doi:10.1001/jama.2018.9185 · Cited by 9
Management of Device-detected Atrial High-rate Episodes
Tomson, T. T., & PASSMAN, R. S. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.05.010 · Cited by 10
Estimating the incidence of atrial fibrillation in single‐chamber implantable cardioverter defibrillator patients
ZWEIBEL, S. L., Cronin, E. M., Schloss, E. J., Auricchio, A., Kurita, T., Sterns, L. D., Gerritse, B., Lexcen, D. R., & Cheng, A. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13555 · Cited by 9
Clinical classification and the subclinical atrial fibrillation challenge: a position paper of the European Cardiac Arrhythmia Society
Lévy, S., Santini, L., Cappato, R., Steinbeck, G., Capucci, A., & Saksena, S. V. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00859-y · Cited by 9
Self-citation
Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study)
Verma, A., Wachter, R., Kowey, P. R., Halperin, J. L., Gersh, B. J., Elkind, M. S. V., Kaplon, R. E., Ziegler, P., Sherfesee, L., & Reiffel, J. A. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.06.006 · Cited by 8
Atrial Fibrillation Monitoring in Cryptogenic Stroke: the Gaps Between Evidence and Practice
Akrawinthawong, K., Prasad, K. R., MEHDIRAD, A. A., & Ferreira, S. W. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0674-9 · Cited by 8
Wireless remote monitoring of atrial fibrillation using reconstructed 12-lead ECGs
Vukajlovic, D. D., Bojovic, B., Hadžievski, L. R., George, S., Gussak, I. B., & Panescu, D. (2010) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2010.5627086 · Cited by 8
How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey
TODD, D. M., Hernández‐Madrid, A., Proclemer, A., Bongiorni, M. G., Estner, H., & Blomström‐Lundqvist, C. (2015) · EP Europace · doi:10.1093/europace/euv310 · Cited by 8
Subclinical Atrial Tachyarrhythmias:Implantable Devices and Remote Monitoring.
Maria, E. D., & Giacopelli, D. (2015) · PubMed Central · doi:10.4022/jafib.1249 · Cited by 8
Asymptomatic atrial fibrillation burden and thromboembolic events: piecing evidence together
Proietti, R., Labos, C., AlTurki, A., Essebag, V., Glotzer, T. V., & Verma, A. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1154457 · Cited by 9
How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring
Lip, G. Y. H. (2016) · Circulation · doi:10.1161/circulationaha.115.016797 · Cited by 7
Atrial Fibrillation in Kidney Failure: Challenges in Risk Assessment and Anticoagulation Management
Law, M. M., Tan, S., Wong, M. C. G., & Toussaint, N. D. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100690 · Cited by 7
Using Atrial Fibrillation Burden Trends and Machine Learning to Predict Near-Term Risk of Cardiovascular Hospitalization
Peacock, J. M., Stanelle, E. J., Johnson, L. C., Hylek, E. M., Kanwar, R., Lakkireddy, D., Mittal, S., PASSMAN, R. S., Russo, A. M., Soderlund, D. M., et al. (2024) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.124.012991 · Cited by 7
Smartphone and new tools for atrial fibrillation diagnosis: evidence for clinical applicability
PAPACCIOLI, G., BASSI, G., Cecilia, L. U. G. I., Parente, E., D’ANDREA, A., PROIETTI, R., Imbalzano, E., TURKI, A. A., & Russo, V. (2022) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.22.05841-0 · Cited by 7
Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery
O’Shea, C., Brooks, A. G., Middeldorp, M. E., Harper, C., Hendriks, J., Russo, A. M., Freeman, J. V., Gopinathannair, R., Varma, N., Deering, T. F., et al. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01481-4 · Cited by 7
The Importance of Atrial Fibrillation Burden and the Origin of Device‐Tailored Anticoagulation
ZIMETBAUM, P. J., Ellis, E. R., Waks, J. W., & PASSMAN, R. S. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12275 · Cited by 7
Clinical Utility of Implantable Loop Recorders
Houmsse, M., Ishola, A., & Daoud, E. G. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.03.2738 · Cited by 7
Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Weijs, B., Schotten, U., & Crijns, H. J. G. M. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140825150057 · Cited by 7
Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?
Lenarczyk, R., Jędrzejczyk‐Patej, E., Szulik, M., Mazurek, M., Podolecki, T., Kowalczyk, J. P., Kowalski, O., Średniawa, B., & Kalarus, Z. F. (2015) · Cardiology Journal · doi:10.5603/cj.a2014.0102 · Cited by 7
Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
Cori, A. D., Lilli, A., Zucchelli, G., & Zacà, V. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1438267 · Cited by 8
Detection of atrial fibrillation in asymptomatic at-risk individuals
Langer, A., Healey, J. S., Quinn, F. R., Honos, G. N., Nault, I., Tan, M., Camara, D., Newman, D. M., & Godin, R. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.04.048 · Cited by 7
The Importance of Arrhythmia Burden for Outcomes and Management Related to Catheter Ablation of Atrial Fibrillation
Sánchez-Somonte, P., Gül, E. E., & Verma, A. (2021) · Korean Circulation Journal · doi:10.4070/kcj.2021.0077 · Cited by 7
The year in arrhythmias—2009: Part I
Olshansky, B., Delmar, M., & Tomaselli, G. F. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.12.011 · Cited by 7
Device-identified atrial fibrillation at pacing clinics. Should it guide anticoagulation?
Merinopoulos, I., Raphael, C. E., Yardley, A., Goonewardene, M., & Vassiliou, V. S. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.040 · Cited by 7
Managing atrial fibrillation in the global community: The European perspective
Kaba, R. A., Camm, A. J., Williams, T. M., & Sharma, R. (2013) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2013.24 · Cited by 6
Paroxysmal Atrial Fibrillation: Novel Strategies for Monitoring and Implications for Treatment in Stroke
Silverman, S. B. (2016) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-016-0475-5 · Cited by 6
Monitoring Atrial Fibrillation After Catheter Ablation.
Forleo, G. B., Casella, M., Russo, A. D., Moltrasio, M., Fassini, G., Tesauro, M., & Tondo, C. (2014) · PubMed Central · doi:10.4022/jafib.1040 · Cited by 6
Detection of Previously Unrecognized (Subclinical) Atrial Fibrillation
Kochav, S. M., & Reiffel, J. A. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.04.013 · Cited by 6
Preserve the Brain
Prystowsky, E. N., & Padanilam, B. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.038 · Cited by 6
Importance of monitoring zones in the detection of arrhythmias in patients with implantable cardioverter-defibrillators under remote monitoring
Rosa, S. A., Cunha, P. S., Lousinha, A., Valente, B. T., Delgado, A. S., Pimenta, R., Brás, M., Cruz, M. C., Portugal, G., Monteiro, A. V., et al. (2019) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2018.05.015 · Cited by 5
The value of serial echocardiography in risk assessment of patients with paroxysmal atrial fibrillation
Leung, M., van Rosendael, P. J., van der Bijl, P., Regeer, M. V., van Wijngaarden, S. E., Leung, D. Y., Delgado, V., Marsan, N. A., Ng, A. C. T., & Bax, J. J. (2023) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-023-03014-6 · Cited by 5
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit
McIntyre, W. F., Benz, A. P., Tojaga, N., Brandes, A., Lópes, R. D., & Healey, J. S. (2024) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suae075 · Cited by 5
Atrial High-Rate Episodes and Subclinical Atrial Fibrillation: State of the Art and Clinical Questions with Complex Solutions
Brookles, C. G., Ponti, R. D., Russo, V., Ziacchi, M., Pelargonio, G., Casella, M., Lauretti, M., Vilotta, M., Themistoclakis, S., D’Onofrio, A., et al. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2508305 · Cited by 5
Self-citation
AF Detected on Implanted Cardiac Implantable Electronic Devices: Is There a Threshold for Thromboembolic Risk?
Baibars, M., Kanjwal, K., & Marine, J. E. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0289-7 · Cited by 5
Atrial Fibrillation and Stroke: The Evolving Role of Rhythm Control
Patel, T. K., & PASSMAN, R. S. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0234-9 · Cited by 5
Cryptogenic stroke and diabetes: a probable link between silent atrial fibrillation episodes and cerebrovascular disease
Marfella, R., Rizzo, M. R., Capoluongo, M. C., Ambrosino, M., Antonella, S., Cinone, F., Martinelli, G., Fava, I., Petrella, A., Barbieri, M., et al. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.882230 · Cited by 5
Long-term follow-up case study of atrial fibrillation after treatment
Jan, M., & Trobec, R. (2017) · International Convention on Information and Communication Technology, Electronics and Microelectronics · doi:10.23919/mipro.2017.7973438 · Cited by 5
Long-term rhythm monitoring with an implantable loop recorder in patients after the first clinical atrial fibrillation episode. Towards an individualized management
Papakonstantinou, P. Ε., & SIMANTIRAKIS, E. N. (2019) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.19.04883-7 · Cited by 5
Remote Monitoring of Permanent Pacemakers and Implantable Cardioverter Defibrillators
Wilner, B. R., & Rickard, J. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2021.04.005 · Cited by 5
Stroke risk in patients with device-detected atrial high-rate episodes
Erküner, Ö., Rienstra, M., Gelder, I. C. V., Schotten, U., Crijns, H. J. G. M., & LUERMANS, J. G. L. M. (2017) · Netherlands Heart Journal · doi:10.1007/s12471-017-1047-3 · Cited by 5
When Silence Isn’t Golden: The Case of “Silent” Atrial Fibrillation
Reiffel, J. A. (2017) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2017.081102 · Cited by 5
Remote Monitoring of Atrial High Rate Episodes in Pacemaker Patients. The Rapid Study Design
Russo, V. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2100 · Cited by 5
Undetected paroxysmal atrial fibrillation in chronic heart failure patients: is it clinically relevant to catch the atrial phantom?
Pisters, R., de Vos, C. B., Dennert, R. M., & Crijns, H. J. G. M. (2009) · EP Europace · doi:10.1093/europace/eup268 · Cited by 5
Cost-effectiveness analysis of cardiac implantable electronic devices with reactive atrial-based antitachycardia pacing
Noda, T., Ueda, N., Tanaka, Y., Ishiguro, Y., Matsumoto, T., Uenishi, T., Yamaguchi, H., Shoji, A., Myung, J.-E., & KUSANO, K. F. (2023) · EP Europace · doi:10.1093/europace/euad003 · Cited by 4
Non-invasive mid-term electrocardiogram patch monitoring is effective in detecting atrial fibrillation
Cai, X. J., Tay, J. C. K., Jiang, Y., Yeo, K. K., Wong, P. E. H., Ho, K. L., Chong, D., Ti, L. K., Leong, G. K. T., Wong, K. C. K., et al. (2023) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2023.09.014 · Cited by 4
Atrieflimmer og hjerneslag
Aamodt, A. H., Sandset, P. M., Atar, D., Tveit, A., & Russell, D. (2013) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0850 · Cited by 4
New atrial fibrillation diagnosed by 30-day rhythm monitoring
Farris, G. R., Smith, B. G., Oates, E. T., Colon, C. M., & Doppalapudi, H. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.11.003 · Cited by 4
Device-detected atrial sensing amplitudes as a marker of increased risk for new onset and progression of atrial high-rate episodes
Biffi, M., Celentano, E., Giammaria, M., Curnis, A., Rovaris, G., Ziacchi, M., Miracapillo, G., Saporito, D., Baroni, M., Quartieri, F., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.03.034 · Cited by 4
Self-citation
Use of an Atrial Lead with Very Short Tip-To-Ring Spacing Avoids Oversensing of Far-Field R-Wave
Kolb, C., Nölker, G., Lennerz, C., Jetter, H., Semmler, V., Pürner, K., Gutleben, K., Reents, T., Lang, K., Lotze, U., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038277 · Cited by 4
Stroke Prevention in Atrial Fibrillation
Szapáry, L. B. (2015) · Journal of Clinical Trials in Cardiology · doi:10.15226/2374-6882/2/4/00132 · Cited by 4
Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
Horjen, A. W., Seljeflot, I., Berge, T., Smith, P., Arnesen, H., & Tveit, A. (2017) · Thrombosis Journal · doi:10.1186/s12959-017-0153-1 · Cited by 4
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions
Hyman, D. A., Siebert, V., Jia, X., Alam, M., Levine, G. N., Virani, S. S., & Birnbaum, Y. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-06849-7 · Cited by 6
Prediction of mortality in patients with implantable defibrillator using CHADS2 score: data from a prospective observational investigation.
Morani, G., Facchin, D., Molon, G., Zanotto, G., Maines, M., Zoppo, F., Themistoclakis, S., Allocca, G., Dametto, E., Bertaglia, E., et al. (2018) · Europe PMC (PubMed Central) · Cited by 4
Self-citation
Preserving Cognitive Function in Patients with Atrial Fibrillation.
Lin, T., Wißner, E., Tilz, R. R., Rillig, A., Mathew, S., Rausch, P., Rausch, P., Lemeš, C., Deiß, S., Kamioka, M., et al. (2014) · PubMed Central · doi:10.4022/jafib.980 · Cited by 4
P-wave indices in Japanese patients with ischemic stroke: Implication of atrial myopathy in subtype of ischemic stroke
Yamamoto, S., Ono, H., Motoyama, H., Tachikawa, H., Tagawa, M., Akazawa, K., & Aizawa, Y. (2021) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2021.02.010 · Cited by 4
The Role of Implantable Devices to Treat Atrial Fibrillation
Santini, L., & Santini, M. (2015) · Future Cardiology · doi:10.2217/fca.15.61 · Cited by 3
Self-citation
Stroke Prevention in Atrial Fibrillation – The Unmet Need and Morbidity Burden
Camm, A. J. (2011) · European Cardiology Review · doi:10.15420/ecr.2011.7.3.187 · Cited by 3
Cardiac electrophysiological characteristics of silent paroxysmal atrial fibrillation: What causes asymptomaticity?
Hironobe, N., Sairaku, A., Nakano, Y., Tokuyama, T., Okamura, S., Okubo, Y., Shimizu, W., & Kihara, Y. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14216 · Cited by 3
Atrial fibrillation: focus on monitoring strategies after cryptogenic stroke
BUONO, M. G. D., & SANNA, T. (2022) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.21.05851-8 · Cited by 3
Use of Prolonged Cardiac Rhythm Monitoring to Identify Atrial Fibrillation After Cryptogenic Stroke
Roy, A. T., Schwamm, L. H., & Singhal, A. B. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01652-1 · Cited by 3
Challenging anticoagulation decisions in atrial fibrillation: a narrative review
Griffin, M., Proietti, R., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2024) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447241290429 · Cited by 3
Implantable Cardiac Rhythm and Hemodynamic Monitors
Daly, M. G., Melton, I., & Crozier, I. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00025-0 · Cited by 3
When is Device-Detected Atrial Fibrillation Actionable?
Wasserlauf, J., & PASSMAN, R. S. (2018) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.11.007 · Cited by 3
Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation
Matos, J. D., Waks, J. W., & ZIMETBAUM, P. J. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090404 · Cited by 3
Devicebasiertes Telemonitoring
Duncker, D., Michalski, R., Müller‐Leisse, J., Zormpas, C., König, T., & Veltmann, C. (2017) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-017-0521-3 · Cited by 3
Does Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices Have Clinical Relevance?
Glotzer, T. V., & Ziegler, P. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2013.11.001 · Cited by 3
Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary
Waks, J. W., & ZIMETBAUM, P. J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.849572 · Cited by 3
Rate Control in Atrial Fibrillation: Methods for Assessment, Targets for Ventricular Rate during AF, and Clinical Relevance for Device Therapy.
Sarkar, S., & Ziegler, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.791 · Cited by 3
Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial
Yang, Y., Xu, F., Tong, J., Cai, L., Jiang, W., Sheng, X., Pan, Y., Jiang, J., Zhang, J., Jiang, D., et al. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6807-9 · Cited by 3
Electrical manipulation of the failing heart
Zacà, V., Murphy, T. M., & Biffi, M. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9732-x · Cited by 3
Self-citation
The Importance and Future of Population Screening for Atrial Fibrillation
Shin, S. Y., & Lip, G. Y. H. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.016 · Cited by 3
Remote Monitoring of Atrial High Rate Episodes in Pacemaker Patients. The Rapid Study Design.
Russo, V., Rago, A., Tavoletta, V., Bianchi, V., Carella, C., Ammirati, G., Viggiano, A., Vivo, S. D., Rapacciuolo, A., Nigro, G., et al. (2018) · Europe PMC (PubMed Central) · doi:10.4022/jafib.2075 · Cited by 3
Atrial Fibrillation
Issa, Z. F., Miller, J. M., & Zipes, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-1274-8.00015-4 · Cited by 3
The Link Between CHA2DS2-VASc Score and Thromboembolic Risk in Patients Without Known Atrial Fibrillation: Are We Missing a Silent Culprit?
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2303 · Cited by 3
The Cacophony of Silent Atrial Fibrillation
Glotzer, T. V. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.520 · Cited by 3
Electrocardiographic Monitoring Strategies (Holter, Implantable Loop Recorder, in Between)
Nazzari, H., Halperin, L. F., & Krahn, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99770-9 · Cited by 3
Additional Stroke Risk Factors Beyond the CHA2DS2-VA Score in Non-Valvular Atrial Fibrillation: An Interdisciplinary Expert Opinion
Şimşek, E. Ç., Şekerci, S. S., Gücün, M., Tanrıkulu, S., Ahi, E. D., Ozdengulsun, B., & Aras, D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15051758 · Cited by 2
Atrial fibrillation detected by dual-chamber pacemakers and structural heart disease
Görenek, B., & Kudaiberdieva, G. (2009) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2009.03.003 · Cited by 2
Stroke Risk in Patients with Implanted Cardiac Devices
Houmsse, M., & Daoud, E. G. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.10.002 · Cited by 2
Primary prevention of atrial fibrillation by statins: still unresolved?
Crijns, H. J. G. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp362 · Cited by 2
Implantable loop recorders in patients with atrial fibrillation
Sharma, A. N., McIntyre, W. F., Nguyen, S. T., & Baranchuk, A. M. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2153673 · Cited by 2
Use of Anticoagulation for Thromboembolic Prophylaxis in Patients With Atrial High-Rate Episodes on Device Monitoring: A Narrative Review
Leung, A. N. W., & Bhat, A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.11.009 · Cited by 2
The additional value of an algorithm for atrial fibrillation at the stroke unit
van der Maten, G., Plas, G. J. J., Meijs, M. F. L., Brouwers, P. J. A. M., Brusse-Keizer, M. G. J., & den Hertog, H. M. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104930 · Cited by 2
Subclinical atrial fibrillation: when to give NAO?
Patti, G., & Sticchi, A. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa072 · Cited by 2
Does catheter ablation of atrial fibrillation eliminate the need for anticoagulation?
Mahajan, R., Pathak, R. K., Lim, H. S., Willoughby, S. R., & Sanders, P. (2013) · Interventional Cardiology · doi:10.2217/ica.13.2 · Cited by 2
Advances in the Detection and Monitoring of Atrial Fibrillation for Patients with Cryptogenic Ischemic Stroke
Sangha, R. S., & Bernstein, R. A. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0544-3 · Cited by 2
Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk
Abrignani, M. G., & Colivicchi, F. (2015) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2013.80 · Cited by 2
Empirical anticoagulation for patients in sinus rhythm at high risk of ischaemic stroke: A review of current literature
Battipaglia, I., O’Neill, J., Hogarth, A. J., & Tayebjee, M. H. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i5.422 · Cited by 2
What we have learned from the European Heart Rhythm Association consensus document on device-detected subclinical atrial tachyarrhythmias
Özcan, E. E. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.8223 · Cited by 2
Clinical outcomes in patients with systolic heart failure. Are atrial high rate episodes a common marker of disease progression?
Botto, G. L., & Healey, J. S. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.04.077 · Cited by 2
Self-citation

Authors: BOTTO, G. L., PADELETTI, L., SANTINI, M., CAPUCCI, A., GULIZIA, M., ZOLEZZI, F., FAVALE, S., MOLON, G., RICCI, R., BIFFI, M., RUSSO, G., VIMERCATI, M., CORBUCCI, G., & BORIANI, G.
Affiliations: Ospedale Sant'Anna (IT)
University of Florence (IT)
Ospedale San Filippo Neri (IT)
Guglielmo da Saliceto Hospital (IT)
Ospedale Garibaldi (IT)
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
Ospedale Sacro Cuore Don Calabria (IT)
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
Medtronic (Italy) (IT)
Corresponding author: BOTTO, GIOVANNI L.
RUSSO, GIOVANNI
ORCID: BOTTO, GIOVANNI L.
GULIZIA, MICHELE
FAVALE, STEFANO
MOLON, GIULIO
RICCI, RENATO
BIFFI, MAURO
BORIANI, GIUSEPPE
Venue: Journal of Cardiovascular Electrophysiology
Publisher: Wiley
Published: 2009-02-20
Volume: 20
Issue: 3
Pages: 241-248
ISSN: 1045-3873 (ISSN-L)
1540-8167
DOI: 10.1111/j.1540-8167.2008.01320.x
OpenAlex: W2075749661
Cited by: 380
References: 40
Citations by year: 2026: 4 · 2025: 3 · 2024: 15 · 2023: 17 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 19 · 2018: 37 · 2017: 31 · 2016: 30 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 26
FWCI: 11.16
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Cardiovascular Electrophysiology (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Florence Research (University of Florence) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, thromboembolic risk, CHADS2 score, atrial fibrillation duration, continuous cardiac monitoring, Holter monitoring, intermittent monitoring, stroke risk stratification, implantable pacemaker, asymptomatic atrial fibrillation, anticoagulation, antiplatelet therapy, antiarrhythmic drugs, catheter ablation
MeSH terms: Aged, Atrial Fibrillation, Female, Humans, Italy, Male, Prognosis, Risk Factors, Thromboembolism, Electrocardiography, Ambulatory, Comorbidity, Incidence, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks